Daniel O’Day, Gilead chairman and CEO (Photo by Jim Watson/AFP via Getty Images)

Gilead leads HIV grant­mak­ers list, tops Gates Foun­da­tion in a first for an­nu­al sur­vey

Gilead Sci­ences’ $100 mil­lion pledge to fight the HIV epi­dem­ic in the south­ern US states helped boost the bio­phar­ma to the top of an an­nu­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.